Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

31P-MRS and MRI Imaging in Semaglutide Study

NCT07695454 is registered in ClinicalTrials.gov with The Cleveland Clinic as lead sponsor.

NCT NCT07695454
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07695454 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
31P-MRS and MRI Imaging in Semaglutide Study
Lead sponsor
The Cleveland Clinic
Phase
Observational
Overall status
Recruiting
Start date
July 30, 2026
Completion date
June 1, 2027
Enrollment
10 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bmi greater than 30, type 2 diabetes